388 related articles for article (PubMed ID: 27613196)
1. Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Greer IA; Zotz RB
Blood; 2016 Nov; 128(19):2343-2349. PubMed ID: 27613196
[TBL] [Abstract][Full Text] [Related]
2. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
van Vlijmen EF; Wiewel-Verschueren S; Monster TB; Meijer K
J Thromb Haemost; 2016 Jul; 14(7):1393-403. PubMed ID: 27121914
[TBL] [Abstract][Full Text] [Related]
3. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis.
Croles FN; Nasserinejad K; Duvekot JJ; Kruip MJ; Meijer K; Leebeek FW
BMJ; 2017 Oct; 359():j4452. PubMed ID: 29074563
[No Abstract] [Full Text] [Related]
5. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A.
Federici EH; Al-Mondhiry H
Thromb Res; 2019 Oct; 182():75-78. PubMed ID: 31472339
[TBL] [Abstract][Full Text] [Related]
6. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
7. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk.
Ziakas PD; Poulou LS; Pavlou M; Zintzaras E
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():106-11. PubMed ID: 26115054
[TBL] [Abstract][Full Text] [Related]
8. Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
Saemundsson Y; Sveinsdottir SV; Svantesson H; Svensson PJ
J Thromb Thrombolysis; 2013 Oct; 36(3):324-31. PubMed ID: 23054468
[TBL] [Abstract][Full Text] [Related]
9. Oral contraception in women with mild thrombophilia: what have we learned recently?
Blanco-Molina Á
Thromb Res; 2012 Oct; 130 Suppl 1():S16-8. PubMed ID: 23026651
[TBL] [Abstract][Full Text] [Related]
10. Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism.
Coppola A; Tufano A; Cerbone AM; Di Minno G
Semin Thromb Hemost; 2009 Oct; 35(7):683-94. PubMed ID: 20013535
[TBL] [Abstract][Full Text] [Related]
11. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
Sveinsdottir SV; Saemundsson Y; Isma N; Gottsäter A; Svensson PJ
Thromb Res; 2012 Sep; 130(3):467-71. PubMed ID: 22512897
[TBL] [Abstract][Full Text] [Related]
13. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
Marchiori A; Mosena L; Prins MH; Prandoni P
Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
[TBL] [Abstract][Full Text] [Related]
14. Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias.
Villani M; Tiscia GL; Margaglione M; Colaizzo D; Fischetti L; Vergura P; Grandone E
J Thromb Haemost; 2012 Feb; 10(2):223-8. PubMed ID: 22136658
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
[TBL] [Abstract][Full Text] [Related]
16. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
17. Genetic Risk Factors in Venous Thromboembolism.
Hotoleanu C
Adv Exp Med Biol; 2017; 906():253-272. PubMed ID: 27638626
[TBL] [Abstract][Full Text] [Related]
18. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism.
Caiano L; Kovacs MJ; Lazo-Langner A; Anderson DR; Kahn SR; Shah V; Kaatz S; Zide RS; Schulman S; Chagnon I; Mallick R; Rodger MA; Wells PS
J Thromb Haemost; 2023 Mar; 21(3):553-558. PubMed ID: 36710196
[TBL] [Abstract][Full Text] [Related]
19. Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Roy DC; Wang TF; Carrier M; Mallick R; Burger D; Hawken S; Wells PS
J Thromb Haemost; 2023 Nov; 21(11):3184-3192. PubMed ID: 37536569
[TBL] [Abstract][Full Text] [Related]
20. FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.
Kovac M; Mikovic D; Antonijevic N; Rakicevic L; Djordjevic V; Radojkovic D; Elezovic I
J Thromb Thrombolysis; 2008 Jun; 25(3):284-7. PubMed ID: 17549437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
